Financhill
Back

Reitmans (Canada) Vs. PTC Therapeutics Industry Stock Comparison

Sell
38

RET.A.V
Reitmans (Canada)

Last Price:
2.35
Seasonality Move:
48.35%
Sell
35

PTCT
PTC Therapeutics

Last Price:
30.95
Seasonality Move:
8.11%
Sell
38
Reitmans (Canada) (RET.A.V) is a Sell

Is Reitmans (Canada) a Buy, Sell or Hold?

  • The current Reitmans (Canada) [RET.A.V] share price is $2.35. The Score for RET.A.V is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RET.A.V is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $30.93. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RET.A.V Stock Price Chart

What is Reitmans (Canada)'s stock price today?

  • The Reitmans (Canada) share price today is $2.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RET.A.V is experiencing slight buying pressure.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $30.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.

RET.A.V Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.8 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.44) Sell
Bollinger Bands (100): (2.38 - 2.52) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.07 Sell
Relative Strength Index (14 RSI): 37.86 Sell
Chaikin Money Flow: 253548 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.75 - 37.67) Sell
Bollinger Bands (100): (26.98 - 35.24) Sell

RET.A.V Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.38 Sell
20-day SMA: 2.41 Sell
50-day SMA: 2.41 Sell
200-day SMA: 2.46 Sell
8-day EMA: 2.38 Sell
20-day EMA: 2.4 Sell
50-day EMA: 2.42 Sell
200-day EMA: 2.51 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.36 Sell
20-day SMA: 34.73 Sell
50-day SMA: 34.22 Sell
200-day SMA: 27.63 Buy
8-day EMA: 32.12 Sell
20-day EMA: 33.74 Sell
50-day EMA: 33.49 Sell
200-day EMA: 31.79 Sell

Reitmans (Canada) Earnings Growth & RET.A.V Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Reitmans (Canada) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):